# EDGAR Filing Document

**Accession Number:** 0001795091
**File Stem:** 0001213900-25-050099
**Filing Date:** 2025-6
**Character Count:** 2702
**Document Hash:** 8cb45e5bb65d9bb7d35283377d1e59eb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-050099.hdr.sgml**: 20250708

**ACCESSION NUMBER**: 0001213900-25-050099

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20250602

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OS Therapies Inc
- **CENTRAL INDEX KEY:** 0001795091
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 825118368
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 15825 SHADY GROVE ROAD
- **STREET 2:** SUITE 135
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850
- **BUSINESS PHONE:** 410-297-7793

**MAIL ADDRESS:**
- **STREET 1:** 15825 SHADY GROVE ROAD
- **STREET 2:** SUITE 135
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OS THERAPIES Inc
- **DATE OF NAME CHANGE:** 20191125

![](image_001.jpg)

EMAIL: SFeldman@olshanlaw.com

DIRECT DIAL: 212.451.2234

June 2, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, D.C. 20549

Attn.: Joshua Gorsky Office of Life Sciences

Re: OS Therapies Incorporated<br> <u>Registration Statement on Form S-1 (No. 333-287569)</u>

Ladies and Gentlemen:

On behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

Please advise the undersigned of the effectiveness of the Registration Statement.

---

| |
|:---|
| Very truly yours, |
| /s/ Spencer G. Feldman |
| Spencer G. Feldman |

---

cc: Paul A. Romness, MPH

![](image_002.jpg)

![](image_003.jpg)

June 2, 2025

U.S. Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, D.C. 20549

Attn.: Joshua Gorsky Office of Life Sciences

Re: OS Therapies Incorporated<br> <u>Registration Statement on Form S-1 (No. 333-287569)</u>

Ladies and Gentlemen:

OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **OS Therapies Incorporated** | **OS Therapies Incorporated** |
| By: | /s/ Paul A. Romness |
|  | Paul A. Romness |
|  | President and Chief Executive Officer |

---